2015-2025 Global Breakthrough Therapy (BT) Designation Market Research by Type, End-Use and Region (COVID-19 Version)
SUMMARY
The global Breakthrough Therapy (BT) Designation market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Key Companies
The global Breakthrough Therapy (BT) Designation market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
- Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
- Chapter 2: Global Production & Consumption Market by Type and End-Use
- Chapter 3: Europe Production & Consumption Market by Type and End-Use
- Chapter 4: America Production & Consumption Market by Type and End-Use
- Chapter 5: Asia Production & Consumption Market by Type and End-Use
- Chapter 6: Oceania Production & Consumption Market by Type and End-Use
- Chapter 7: Africa Production & Consumption Market by Type and End-Use
- Chapter 8: Global Market Forecast by Type, End-Use and Region
- Chapter 9: Company information, Sales, Cost, Margin, news etc.
- Chapter 10: Market Competition by Companies and Market Concentration Ratio
- Chapter 11: Market Impact by Coronavirus.
- Chapter 12: Industry Summary
Key Companies
- Roche
- Abbvie
- Novartis International AG
- Janssen
- BMS
- Eli Lilly
- Gilead
- Sanofi
- Regeneron
- Acadia
- Boehringer Ingelheim
- Amgen
- AstraZeneca
- GlaxoSmithKline
- Vertex
- Alexion
- Merck
- Jazz Pharmaceuticals
- Exelixis
- Eisai
- Takeda
- Pfizer
- Oncology
- Infectious Diseases
- Rare Diseases
- Autoimmune Diseases
- Pulmonary Diseases
- Neurological Disorders
- Others
- Hospital
- Clinic
- Research Institute
- Laboratories
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBreakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure America Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure America Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Asia Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Africa Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Breakthrough Therapy (BT) Designation Production Forecast
Figure Global Breakthrough Therapy (BT) Designation Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Breakthrough Therapy (BT) Designation Forecast by Type
Table Global Breakthrough Therapy (BT) Designation Revenue by Type, 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2025 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Production Volume by Type, 2020E-2025F (Volume)
Figure Global Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2025 (Volume)
8.3 Global Breakthrough Therapy (BT) Designation Forecast by End-Use (2020E-2025F)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Breakthrough Therapy (BT) Designation Forecast by Region (2020E-2025F)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by Region in 2025 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Breakthrough Therapy (BT) Designation Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Roche
9.1.1 Roche Profile
Table Roche Overview List
9.1.2 Roche Products & Services
9.1.3 Roche Company Dynamics & News
9.1.4 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Abbvie
9.2.1 Abbvie Profile
Table Abbvie Overview List
9.2.2 Abbvie Products & Services
9.2.3 Abbvie Company Dynamics & News
9.2.4 Abbvie Business Operation Conditions
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Novartis International AG
9.3.1 Novartis International AG Profile
Table Novartis International AG Overview List
9.3.2 Novartis International AG Products & Services
9.3.3 Novartis International AG Company Dynamics & News
9.3.4 Novartis International AG Business Operation Conditions
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Janssen
9.4.1 Janssen Profile
Table Janssen Overview List
9.4.2 Janssen Products & Services
9.4.3 Janssen Company Dynamics & News
9.4.4 Janssen Business Operation Conditions
Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 BMS
9.5.1 BMS Profile
Table BMS Overview List
9.5.2 BMS Products & Services
9.5.3 BMS Company Dynamics & News
9.5.4 BMS Business Operation Conditions
Table Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Eli Lilly
9.6.1 Eli Lilly Profile
Table Eli Lilly Overview List
9.6.2 Eli Lilly Products & Services
9.6.3 Eli Lilly Company Dynamics & News
9.6.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Gilead
9.7.1 Gilead Profile
Table Gilead Overview List
9.7.2 Gilead Products & Services
9.7.3 Gilead Company Dynamics & News
9.7.4 Gilead Business Operation Conditions
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Sanofi
9.8.1 Sanofi Profile
Table Sanofi Overview List
9.8.2 Sanofi Products & Services
9.8.3 Sanofi Company Dynamics & News
9.8.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Regeneron
9.9.1 Regeneron Profile
Table Regeneron Overview List
9.9.2 Regeneron Products & Services
9.9.3 Regeneron Company Dynamics & News
9.9.4 Regeneron Business Operation Conditions
Table Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Acadia
9.10.1 Acadia Profile
Table Acadia Overview List
9.10.2 Acadia Products & Services
9.10.3 Acadia Company Dynamics & News
9.10.4 Acadia Business Operation Conditions
Table Business Operation of Acadia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.11.2 Boehringer Ingelheim Products & Services
9.11.3 Boehringer Ingelheim Company Dynamics & News
9.11.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Amgen
9.12.1 Amgen Profile
Table Amgen Overview List
9.12.2 Amgen Products & Services
9.12.3 Amgen Company Dynamics & News
9.12.4 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)
9.13 AstraZeneca
9.13.1 AstraZeneca Profile
Table AstraZeneca Overview List
9.13.2 AstraZeneca Products & Services
9.13.3 AstraZeneca Company Dynamics & News
9.13.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.14.2 GlaxoSmithKline Products & Services
9.14.3 GlaxoSmithKline Company Dynamics & News
9.14.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
9.15 Vertex
9.15.1 Vertex Profile
Table Vertex Overview List
9.15.2 Vertex Products & Services
9.15.3 Vertex Company Dynamics & News
9.15.4 Vertex Business Operation Conditions
Table Business Operation of Vertex (Sales Revenue, Cost, Gross Margin)
9.16 Alexion
9.16.1 Alexion Profile
Table Alexion Overview List
9.16.2 Alexion Products & Services
9.16.3 Alexion Company Dynamics & News
9.16.4 Alexion Business Operation Conditions
Table Business Operation of Alexion (Sales Revenue, Cost, Gross Margin)
9.17 Merck
9.17.1 Merck Profile
Table Merck Overview List
9.17.2 Merck Products & Services
9.17.3 Merck Company Dynamics & News
9.17.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
9.18 Jazz Pharmaceuticals
9.18.1 Jazz Pharmaceuticals Profile
Table Jazz Pharmaceuticals Overview List
9.18.2 Jazz Pharmaceuticals Products & Services
9.18.3 Jazz Pharmaceuticals Company Dynamics & News
9.18.4 Jazz Pharmaceuticals Business Operation Conditions
Table Business Operation of Jazz Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.19 Exelixis
9.19.1 Exelixis Profile
Table Exelixis Overview List
9.19.2 Exelixis Products & Services
9.19.3 Exelixis Company Dynamics & News
9.19.4 Exelixis Business Operation Conditions
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
9.20 Eisai
9.20.1 Eisai Profile
Table Eisai Overview List
9.20.2 Eisai Products & Services
9.20.3 Eisai Company Dynamics & News
9.20.4 Eisai Business Operation Conditions
Table Business Operation of Eisai (Sales Revenue, Cost, Gross Margin)
9.21 Takeda
9.21.1 Takeda Profile
Table Takeda Overview List
9.21.2 Takeda Products & Services
9.21.3 Takeda Company Dynamics & News
9.21.4 Takeda Business Operation Conditions
Table Business Operation of Takeda (Sales Revenue, Cost, Gross Margin)
9.22 Pfizer
9.22.1 Pfizer Profile
Table Pfizer Overview List
9.22.2 Pfizer Products & Services
9.22.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Breakthrough Therapy (BT) Designation Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Breakthrough Therapy (BT) Designation Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Breakthrough Therapy (BT) Designation Sales Volume by Companies, 2015-2020E (Volume)
Table Global Breakthrough Therapy (BT) Designation Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
Figure America Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
Figure Asia Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
Figure Oceania Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
Figure Africa Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON BREAKTHROUGH THERAPY (BT) DESIGNATION INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 BREAKTHROUGH THERAPY (BT) DESIGNATION INDUSTRY SUMMARY & CONCLUSION
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBreakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure America Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure America Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Asia Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Figure Africa Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Breakthrough Therapy (BT) Designation Production Forecast
Figure Global Breakthrough Therapy (BT) Designation Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Breakthrough Therapy (BT) Designation Forecast by Type
Table Global Breakthrough Therapy (BT) Designation Revenue by Type, 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2025 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Production Volume by Type, 2020E-2025F (Volume)
Figure Global Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2025 (Volume)
8.3 Global Breakthrough Therapy (BT) Designation Forecast by End-Use (2020E-2025F)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Breakthrough Therapy (BT) Designation Forecast by Region (2020E-2025F)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by Region in 2025 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Breakthrough Therapy (BT) Designation Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Roche
9.1.1 Roche Profile
Table Roche Overview List
9.1.2 Roche Products & Services
9.1.3 Roche Company Dynamics & News
9.1.4 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Abbvie
9.2.1 Abbvie Profile
Table Abbvie Overview List
9.2.2 Abbvie Products & Services
9.2.3 Abbvie Company Dynamics & News
9.2.4 Abbvie Business Operation Conditions
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Novartis International AG
9.3.1 Novartis International AG Profile
Table Novartis International AG Overview List
9.3.2 Novartis International AG Products & Services
9.3.3 Novartis International AG Company Dynamics & News
9.3.4 Novartis International AG Business Operation Conditions
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Janssen
9.4.1 Janssen Profile
Table Janssen Overview List
9.4.2 Janssen Products & Services
9.4.3 Janssen Company Dynamics & News
9.4.4 Janssen Business Operation Conditions
Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 BMS
9.5.1 BMS Profile
Table BMS Overview List
9.5.2 BMS Products & Services
9.5.3 BMS Company Dynamics & News
9.5.4 BMS Business Operation Conditions
Table Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Eli Lilly
9.6.1 Eli Lilly Profile
Table Eli Lilly Overview List
9.6.2 Eli Lilly Products & Services
9.6.3 Eli Lilly Company Dynamics & News
9.6.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Gilead
9.7.1 Gilead Profile
Table Gilead Overview List
9.7.2 Gilead Products & Services
9.7.3 Gilead Company Dynamics & News
9.7.4 Gilead Business Operation Conditions
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Sanofi
9.8.1 Sanofi Profile
Table Sanofi Overview List
9.8.2 Sanofi Products & Services
9.8.3 Sanofi Company Dynamics & News
9.8.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Regeneron
9.9.1 Regeneron Profile
Table Regeneron Overview List
9.9.2 Regeneron Products & Services
9.9.3 Regeneron Company Dynamics & News
9.9.4 Regeneron Business Operation Conditions
Table Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Acadia
9.10.1 Acadia Profile
Table Acadia Overview List
9.10.2 Acadia Products & Services
9.10.3 Acadia Company Dynamics & News
9.10.4 Acadia Business Operation Conditions
Table Business Operation of Acadia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.11.2 Boehringer Ingelheim Products & Services
9.11.3 Boehringer Ingelheim Company Dynamics & News
9.11.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Amgen
9.12.1 Amgen Profile
Table Amgen Overview List
9.12.2 Amgen Products & Services
9.12.3 Amgen Company Dynamics & News
9.12.4 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)
9.13 AstraZeneca
9.13.1 AstraZeneca Profile
Table AstraZeneca Overview List
9.13.2 AstraZeneca Products & Services
9.13.3 AstraZeneca Company Dynamics & News
9.13.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.14.2 GlaxoSmithKline Products & Services
9.14.3 GlaxoSmithKline Company Dynamics & News
9.14.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
9.15 Vertex
9.15.1 Vertex Profile
Table Vertex Overview List
9.15.2 Vertex Products & Services
9.15.3 Vertex Company Dynamics & News
9.15.4 Vertex Business Operation Conditions
Table Business Operation of Vertex (Sales Revenue, Cost, Gross Margin)
9.16 Alexion
9.16.1 Alexion Profile
Table Alexion Overview List
9.16.2 Alexion Products & Services
9.16.3 Alexion Company Dynamics & News
9.16.4 Alexion Business Operation Conditions
Table Business Operation of Alexion (Sales Revenue, Cost, Gross Margin)
9.17 Merck
9.17.1 Merck Profile
Table Merck Overview List
9.17.2 Merck Products & Services
9.17.3 Merck Company Dynamics & News
9.17.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
9.18 Jazz Pharmaceuticals
9.18.1 Jazz Pharmaceuticals Profile
Table Jazz Pharmaceuticals Overview List
9.18.2 Jazz Pharmaceuticals Products & Services
9.18.3 Jazz Pharmaceuticals Company Dynamics & News
9.18.4 Jazz Pharmaceuticals Business Operation Conditions
Table Business Operation of Jazz Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.19 Exelixis
9.19.1 Exelixis Profile
Table Exelixis Overview List
9.19.2 Exelixis Products & Services
9.19.3 Exelixis Company Dynamics & News
9.19.4 Exelixis Business Operation Conditions
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
9.20 Eisai
9.20.1 Eisai Profile
Table Eisai Overview List
9.20.2 Eisai Products & Services
9.20.3 Eisai Company Dynamics & News
9.20.4 Eisai Business Operation Conditions
Table Business Operation of Eisai (Sales Revenue, Cost, Gross Margin)
9.21 Takeda
9.21.1 Takeda Profile
Table Takeda Overview List
9.21.2 Takeda Products & Services
9.21.3 Takeda Company Dynamics & News
9.21.4 Takeda Business Operation Conditions
Table Business Operation of Takeda (Sales Revenue, Cost, Gross Margin)
9.22 Pfizer
9.22.1 Pfizer Profile
Table Pfizer Overview List
9.22.2 Pfizer Products & Services
9.22.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Breakthrough Therapy (BT) Designation Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Breakthrough Therapy (BT) Designation Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Breakthrough Therapy (BT) Designation Sales Volume by Companies, 2015-2020E (Volume)
Table Global Breakthrough Therapy (BT) Designation Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
Figure America Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
Figure Asia Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
Figure Oceania Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
Figure Africa Breakthrough Therapy (BT) Designation Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON BREAKTHROUGH THERAPY (BT) DESIGNATION INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 BREAKTHROUGH THERAPY (BT) DESIGNATION INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Europe Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table America Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table America Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Asia Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Africa Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Global Breakthrough Therapy (BT) Designation Revenue by Type, 2020E-2025F (Million USD)
Table Global Breakthrough Therapy (BT) Designation Production Volume by Type, 2020E-2025F (Volume)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2020E-2025F (Volume)
Table Roche Overview List
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbvie Overview List
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis International AG Overview List
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Janssen Overview List
Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BMS Overview List
Table Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Overview List
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Regeneron Overview List
Table Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acadia Overview List
Table Business Operation of Acadia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
Table Vertex Overview List
Table Business Operation of Vertex (Sales Revenue, Cost, Gross Margin)
Table Alexion Overview List
Table Business Operation of Alexion (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Jazz Pharmaceuticals Overview List
Table Business Operation of Jazz Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Exelixis Overview List
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
Table Eisai Overview List
Table Business Operation of Eisai (Sales Revenue, Cost, Gross Margin)
Table Takeda Overview List
Table Business Operation of Takeda (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Global Breakthrough Therapy (BT) Designation Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Breakthrough Therapy (BT) Designation Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Breakthrough Therapy (BT) Designation Sales Volume by Companies, 2015-2020E (Volume)
Table Global Breakthrough Therapy (BT) Designation Sales Volume Share by Companies, 2015-2020E (Volume)
Table Global Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Europe Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table America Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table America Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table America Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Asia Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Breakthrough Therapy (BT) Designation Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Breakthrough Therapy (BT) Designation Revenue by Type, 2015-2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Production Volume by Type, 2015-2020 (Volume)
Table Africa Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Breakthrough Therapy (BT) Designation Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2015-2020 (Volume)
Table Global Breakthrough Therapy (BT) Designation Revenue by Type, 2020E-2025F (Million USD)
Table Global Breakthrough Therapy (BT) Designation Production Volume by Type, 2020E-2025F (Volume)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Breakthrough Therapy (BT) Designation Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Breakthrough Therapy (BT) Designation Consumption Volume by Region, 2020E-2025F (Volume)
Table Roche Overview List
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbvie Overview List
Table Business Operation of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis International AG Overview List
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Janssen Overview List
Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BMS Overview List
Table Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Overview List
Table Business Operation of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Regeneron Overview List
Table Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acadia Overview List
Table Business Operation of Acadia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
Table Vertex Overview List
Table Business Operation of Vertex (Sales Revenue, Cost, Gross Margin)
Table Alexion Overview List
Table Business Operation of Alexion (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Jazz Pharmaceuticals Overview List
Table Business Operation of Jazz Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Exelixis Overview List
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
Table Eisai Overview List
Table Business Operation of Eisai (Sales Revenue, Cost, Gross Margin)
Table Takeda Overview List
Table Business Operation of Takeda (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Global Breakthrough Therapy (BT) Designation Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Breakthrough Therapy (BT) Designation Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Breakthrough Therapy (BT) Designation Sales Volume by Companies, 2015-2020E (Volume)
Table Global Breakthrough Therapy (BT) Designation Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBreakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure America Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure America Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Asia Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Oceania Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Africa Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2025 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2025 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by Region in 2025 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Volume Share by Region in 2025 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBreakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Europe Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure America Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure America Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Asia Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Oceania Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Breakthrough Therapy (BT) Designation Revenue Share by Type in 2020 (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2020 (Volume)
Figure Africa Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Breakthrough Therapy (BT) Designation Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2025 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Production Volume Share by Type in 2025 (Volume)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Value Share by Region in 2025 (Million USD)
Figure Global Breakthrough Therapy (BT) Designation Consumption Volume Share by Region in 2025 (Volume)
